284 related articles for article (PubMed ID: 26215701)
1. RHOBTB3 promotes proteasomal degradation of HIFα through facilitating hydroxylation and suppresses the Warburg effect.
Zhang CS; Liu Q; Li M; Lin SY; Peng Y; Wu D; Li TY; Fu Q; Jia W; Wang X; Ma T; Zong Y; Cui J; Pu C; Lian G; Guo H; Ye Z; Lin SC
Cell Res; 2015 Sep; 25(9):1025-42. PubMed ID: 26215701
[TBL] [Abstract][Full Text] [Related]
2. The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.
Foxler DE; Bridge KS; James V; Webb TM; Mee M; Wong SC; Feng Y; Constantin-Teodosiu D; Petursdottir TE; Bjornsson J; Ingvarsson S; Ratcliffe PJ; Longmore GD; Sharp TV
Nat Cell Biol; 2012 Jan; 14(2):201-8. PubMed ID: 22286099
[TBL] [Abstract][Full Text] [Related]
3. VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma.
Razafinjatovo CF; Stiehl D; Deininger E; Rechsteiner M; Moch H; Schraml P
Oncotarget; 2017 Feb; 8(6):10199-10212. PubMed ID: 28052007
[TBL] [Abstract][Full Text] [Related]
4. von Hippel-Lindau-dependent patterns of RNA polymerase II hydroxylation in human renal clear cell carcinomas.
Yi Y; Mikhaylova O; Mamedova A; Bastola P; Biesiada J; Alshaikh E; Levin L; Sheridan RM; Meller J; Czyzyk-Krzeska MF
Clin Cancer Res; 2010 Nov; 16(21):5142-52. PubMed ID: 20978146
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of integrins by von Hippel-Lindau (VHL) tumor suppressor protein is independent of VHL-directed hypoxia-inducible factor alpha degradation.
Ji Q; Burk RD
Biochem Cell Biol; 2008 Jun; 86(3):227-34. PubMed ID: 18523483
[TBL] [Abstract][Full Text] [Related]
6. Increased hypoxia-inducible factor-1α in striated muscle of tumor-bearing mice.
Devine RD; Bicer S; Reiser PJ; Wold LE
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1154-H1162. PubMed ID: 28341633
[TBL] [Abstract][Full Text] [Related]
7. EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance.
Li S; Rodriguez J; Li W; Bullova P; Fell SM; Surova O; Westerlund I; Topcic D; Bergsland M; Stenman A; Muhr J; Nistér M; Holmberg J; Juhlin CC; Larsson C; von Kriegsheim A; Kaelin WG; Schlisio S
Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16997-17006. PubMed ID: 31375625
[TBL] [Abstract][Full Text] [Related]
8. The Oxygen Sensor PHD2 Controls Dendritic Spines and Synapses via Modification of Filamin A.
Segura I; Lange C; Knevels E; Moskalyuk A; Pulizzi R; Eelen G; Chaze T; Tudor C; Boulegue C; Holt M; Daelemans D; Matondo M; Ghesquière B; Giugliano M; Ruiz de Almodovar C; Dewerchin M; Carmeliet P
Cell Rep; 2016 Mar; 14(11):2653-67. PubMed ID: 26972007
[TBL] [Abstract][Full Text] [Related]
9. von Hippel-Lindau protein promotes Skp2 destabilization on DNA damage.
Roe JS; Kim HR; Hwang IY; Cho EJ; Youn HD
Oncogene; 2011 Jul; 30(28):3127-38. PubMed ID: 21358672
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases.
Chowdhury R; Leung IK; Tian YM; Abboud MI; Ge W; Domene C; Cantrelle FX; Landrieu I; Hardy AP; Pugh CW; Ratcliffe PJ; Claridge TD; Schofield CJ
Nat Commun; 2016 Aug; 7():12673. PubMed ID: 27561929
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase D2 promotes degradation of hypoxia-inducible factor-1α independent of lipase activity.
Park MH; Bae SS; Choi KY; Min do S
Exp Mol Med; 2015 Nov; 47(11):e196. PubMed ID: 26611735
[TBL] [Abstract][Full Text] [Related]
12. Proline hydroxylation and gene expression.
Kaelin WG
Annu Rev Biochem; 2005; 74():115-28. PubMed ID: 15952883
[TBL] [Abstract][Full Text] [Related]
13. Sprouty2 Protein Regulates Hypoxia-inducible Factor-α (HIFα) Protein Levels and Transcription of HIFα-responsive Genes.
Hicks KC; Patel TB
J Biol Chem; 2016 Aug; 291(32):16787-801. PubMed ID: 27281823
[TBL] [Abstract][Full Text] [Related]
14. pVHL interacts with Ceramide kinase like (CERKL) protein and ubiquitinates it for oxygen dependent proteasomal degradation.
Chen J; Liu F; Li H; Archacki S; Gao M; Liu Y; Liao S; Huang M; Wang J; Yu S; Li C; Tang Z; Liu M
Cell Signal; 2015 Nov; 27(11):2314-23. PubMed ID: 26296657
[TBL] [Abstract][Full Text] [Related]
15. Hydroxylation-Dependent Interaction of Substrates to the Von Hippel-Lindau Tumor Suppressor Protein (VHL).
Heir P; Ohh M
Methods Mol Biol; 2016; 1458():87-94. PubMed ID: 27581016
[TBL] [Abstract][Full Text] [Related]
16. TCTP increases stability of hypoxia-inducible factor 1α by interaction with and degradation of the tumour suppressor VHL.
Chen K; Chen S; Huang C; Cheng H; Zhou R
Biol Cell; 2013 May; 105(5):208-218. PubMed ID: 23387829
[TBL] [Abstract][Full Text] [Related]
17. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases.
Chowdhury R; McDonough MA; Mecinović J; Loenarz C; Flashman E; Hewitson KS; Domene C; Schofield CJ
Structure; 2009 Jul; 17(7):981-9. PubMed ID: 19604478
[TBL] [Abstract][Full Text] [Related]
19. Specific oncolytic effect of a new hypoxia-inducible factor-dependent replicative adenovirus on von Hippel-Lindau-defective renal cell carcinomas.
Cuevas Y; Hernández-Alcoceba R; Aragones J; Naranjo-Suárez S; Castellanos MC; Esteban MA; Martín-Puig S; Landazuri MO; del Peso L
Cancer Res; 2003 Oct; 63(20):6877-84. PubMed ID: 14583486
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and characterization of the von Hippel-Lindau-like protein.
Qi H; Gervais ML; Li W; DeCaprio JA; Challis JR; Ohh M
Mol Cancer Res; 2004 Jan; 2(1):43-52. PubMed ID: 14757845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
